Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
1) Pernicious Anaemia Society has a page for health professionals
Results: Our combined protocol was successful in clearing obstructions and achieving our above goals
The specific mechanisms remain under investigation, but the finding adds another dimension to DSIP's systemic regulatory effects
Quality and Sourcing As with any injectable peptide, sourcing matters enormously
Inflammatory bowel syndrome, intestinal lymphomas, vomiting or diarrhea are reported to cause problems in cobalamin absorption